tetano
Editor, Senior Moderator
J Cardiovasc Echogr
. 2023 Jan-Mar;33(1):10-16.
doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29. Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis
Caterina Oriana Aragona[SUP] 1 [/SUP], Gianluca Bagnato[SUP] 1 [/SUP], Simona Tomeo[SUP] 1 [/SUP], Daniela La Rosa[SUP] 1 [/SUP], Marianna Chiappalone[SUP] 1 [/SUP], Maria Concetta Tringali[SUP] 1 [/SUP], Emanuele Balwinder Singh[SUP] 1 [/SUP], Antonio Giovanni Versace[SUP] 1 [/SUP]
Affiliations
Coronavirus disease 2019 (COVID-19) is characterized by multi-organ involvement, including respiratory and cardiac events. Echocardiography is widely considered the first-choice tool for the evaluation of cardiac structures and function because of its reproducibility, feasibility, easy to use at bedside, and for good cost-effectiveness. The aim of our literature review is to define the utility of echocardiography in the prediction of prognosis and mortality in COVID-19 patients with mild to critical respiratory illness, with or without known cardiovascular disease. Moreover, we focused our attention on classical echocardiographic parameters and the use of speckle tracking to predict the evolution of respiratory involvement. Finally, we tried to explore the possible relationship between pulmonary disease and cardiac manifestations.
Keywords: Cardiovascular diseases; coronavirus disease 2019; respiratory failure; severe acute respiratory syndrome coronavirus 2; speckle tracking; transthoracic echocardiography.
. 2023 Jan-Mar;33(1):10-16.
doi: 10.4103/jcecho.jcecho_11_23. Epub 2023 May 29. Echocardiography in Coronavirus Disease 2019 Era: A Single Tool for Diagnosis and Prognosis
Caterina Oriana Aragona[SUP] 1 [/SUP], Gianluca Bagnato[SUP] 1 [/SUP], Simona Tomeo[SUP] 1 [/SUP], Daniela La Rosa[SUP] 1 [/SUP], Marianna Chiappalone[SUP] 1 [/SUP], Maria Concetta Tringali[SUP] 1 [/SUP], Emanuele Balwinder Singh[SUP] 1 [/SUP], Antonio Giovanni Versace[SUP] 1 [/SUP]
Affiliations
- PMID: 37426709
- PMCID: PMC10328134
- DOI: 10.4103/jcecho.jcecho_11_23
Coronavirus disease 2019 (COVID-19) is characterized by multi-organ involvement, including respiratory and cardiac events. Echocardiography is widely considered the first-choice tool for the evaluation of cardiac structures and function because of its reproducibility, feasibility, easy to use at bedside, and for good cost-effectiveness. The aim of our literature review is to define the utility of echocardiography in the prediction of prognosis and mortality in COVID-19 patients with mild to critical respiratory illness, with or without known cardiovascular disease. Moreover, we focused our attention on classical echocardiographic parameters and the use of speckle tracking to predict the evolution of respiratory involvement. Finally, we tried to explore the possible relationship between pulmonary disease and cardiac manifestations.
Keywords: Cardiovascular diseases; coronavirus disease 2019; respiratory failure; severe acute respiratory syndrome coronavirus 2; speckle tracking; transthoracic echocardiography.